Elma Fernandes

Title: Elma Fernandes: Innovator in Polypeptide Research

Introduction

Elma Fernandes is a distinguished inventor based in Branford, CT (US). She has made significant contributions to the field of biotechnology, particularly in the area of polypeptides. With a total of three patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Elma's latest patents include groundbreaking inventions related to FGF-CX. The first patent provides FGF-CX, a novel isolated polypeptide, along with a polynucleotide encoding FGF-CX and antibodies that specifically bind to FGF-CX or its derivatives. This invention also outlines methods for using the FGF-CX polypeptide, polynucleotide, and antibody in the detection and treatment of a wide range of pathological states. The second patent focuses on fibroblast growth factor and nucleic acids encoding the same, further detailing the applications of FGF-CX polypeptides and polynucleotides.

Career Highlights

Elma Fernandes is currently associated with Curagen Corporation, where she continues to advance her research in biotechnology. Her innovative work has positioned her as a key figure in her field, contributing to the understanding and application of polypeptides in medical science.

Collaborations

Elma has collaborated with notable colleagues, including Richard August Shimkets and Michael Jeffers. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.

Conclusion

Elma Fernandes is a remarkable inventor whose work in polypeptide research is paving the way for new medical advancements. Her contributions are not only significant in the realm of biotechnology but also hold promise for future therapeutic applications.